Evidence map›Paper›PMID 21487814›Full record

ReviewDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2011

[Pathology of neuroendocrine neoplasms].

M Anlauf, P Gerlach, M Schott, A Raffel, M Krausch, W T Knoefel, M Pavel, G Klöppel

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Novel prognostic markers revealed by a proteomic approach separating benign from malignant insulinomas.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2015
    Article
  2. [The relevance of PET/CT for the surgical management of neuroendocrine neoplasms].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2014
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. [Extent of resection for neuroendocrine tumors of the small intestine].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2011
    Review
  8. [Gastric neuroendocrine tumors. Endoscopic and surgical treatment].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M AnlaufInstitut für Pathologie, Endokrines Tumorzentrum am Universitätsklinikum Düsseldorf, Moorenstrasse 5, Düsseldorf, Germany. martin.anlauf@med.uni-duesseldorf.de
P Gerlach
M Schott
A Raffel
M Krausch
W T Knoefel
M Pavel
G Klöppel

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the last 5 years the European Neuroendocrine Tumor Society (ENETS) has developed basic recommendations for a standardized pathological diagnosis and classification of neuroendocrine neoplasms (NEN) of the gastroenteropancreatic system. These were included in the novel classification of tumors of the digestive system by the World Health Organization (WHO 2010) and the TNM classification of the union for international cancer control (2009). This review presents the pathology diagnosis regarding (1) basic diagnosis, (2) clinically relevant optional diagnosis, (3) proliferation-based grading, (4) nomenclature and (5) TNM classification. It is emphasized that a standardized diagnosis of NEN, together with clinical and radiological findings, is crucial for prognostic stratification and optimal therapy of patients with NEN. Therefore a close interdisciplinary collaboration is essential.

Indexed as

Biomarkers, TumorCell ProliferationDigestive System NeoplasmsHumansNeoplasm GradingNeoplasm StagingNeuroendocrine TumorsPrognosisTerminology as TopicBiomarkers, Tumor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.